These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24686098)

  • 1. A comparison of the 12s rule and Bayesian approach for quality control: application to one-stage clotting factor VIII assay.
    Sobas F; Tsiamyrtzis P; Benattar N; Lienhart A; Négrier C
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):634-43. PubMed ID: 24686098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of prior manufacturer specifications with Bayesian logic eludes preliminary phase issues in quality control: an example in a hemostasis laboratory.
    Tsiamyrtzis P; Sobas F; Négrier C
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):590-6. PubMed ID: 25978121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal quality control: best practice.
    Kinns H; Pitkin S; Housley D; Freedman DB
    J Clin Pathol; 2013 Dec; 66(12):1027-32. PubMed ID: 24072731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytic variability due to change of deficient plasma vials: application to one-stage clotting factor VIII assay.
    Nougier C; Sobas F; Nguyen TK; Carage ML; Lienhart A; Négrier C
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):151-4. PubMed ID: 21192255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control and factor VIII assays.
    Preston FE; Kitchen S
    Haemophilia; 1998 Jul; 4(4):651-3. PubMed ID: 9873809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian logic in statistical test control: application to coagulation factor VIII assay.
    Sobas F; Bellisario A; Tsiamyrtzis P; Lienhart A; Nougier C; Négrier C
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):289-95. PubMed ID: 20093930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal quality control of a turbidimetric immunoassay for canine serum C-reactive protein based on pooled patient samples.
    Kjelgaard-Hansen M; Jensen AL; Kristensen AT
    Vet Clin Pathol; 2004; 33(3):139-44. PubMed ID: 15334348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal quality control: planning and implementation strategies.
    Westgard JO
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):593-611. PubMed ID: 14629798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In control? IQC consensus and statutory regulation.
    Lee GR; Fitzgibbon MC; O'Shea P
    Int J Health Care Qual Assur; 2016 Jun; 29(5):492-506. PubMed ID: 27256773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the adequate number of internal quality control levels: the example of coagulation factor VIII assay.
    Sobas F; Mazliak L; Bellisario A; Lefranc M; Lienhart A; Nougier C; Négrier C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):433-7. PubMed ID: 18600095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed guidelines for the internal quality control of analytical results in the medical laboratory.
    Petersen PH; Ricós C; Stöckl D; Libeer JC; Baadenhuijsen H; Fraser C; Thienpont L
    Eur J Clin Chem Clin Biochem; 1996 Dec; 34(12):983-99. PubMed ID: 8986407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of clotting factor VIII activity in mammals using the one-stage clotting and the chromogenic methods].
    Lutze G; Lutze G; Kutschmann K; Schröpel M
    Berl Munch Tierarztl Wochenschr; 2002; 115(7-8):297-302. PubMed ID: 12174728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance Assessment of Internal Quality Control (IQC) Products in Blood Transfusion Compatibility Testing in China.
    Xu GP; Wu LF; Li JJ; Gao Q; Liu ZD; Kang QH; Hou YJ; Zhang LC; Hu XM; Li J; Zhang J
    PLoS One; 2015; 10(10):e0141145. PubMed ID: 26488582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal quality control and external quality management of data in practice.
    Methods Mol Biol; 2009; 516():517-41. PubMed ID: 19219595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.
    Duncan EM; Rodgers SE; McRae SJ
    Semin Thromb Hemost; 2013 Apr; 39(3):272-82. PubMed ID: 23460037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IQC Laboratory management strategy for medical biology.
    Bugni E; Cohen R; Mazellier C
    Ann Biol Clin (Paris); 2017 Dec; 75(6):637-645. PubMed ID: 29072175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A collaborative study to establish a Korean Standard for factor VIII:C concentrate.
    Kang HN; Kim SN; Lee SH; Hong SH
    Thromb Res; 2004; 113(3-4):261-7. PubMed ID: 15140591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term automated Bayesian management of IQC results: The experience of the Lyon Hospitals Board hemostasis laboratory].
    Sobas F; Jousselme É; Baillat MG; Cheli E; Dericquebourg A; Nougier C
    Ann Biol Clin (Paris); 2023 May; 81(2):181-188. PubMed ID: 37144779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical application of the patient data-based quality control method: the potassium example.
    Zhang Y; Wang HL; Xie YH; He DH; Zhou CQ; Kong LR
    Biochem Med (Zagreb); 2024 Feb; 34(1):010901. PubMed ID: 38361737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedside measurement of factor VIII:C activity in individuals with hemophilia A.
    Kessler CM; Bernstein Z; Ghesani S; Shamsipour Z; Frances C; Zucker ML; LaDuca FM
    Am J Hematol; 1996 Mar; 51(3):181-5. PubMed ID: 8619397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.